Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pulmonary Medicine

An article in The New York Times reports that the United States Food and Drug Administration (FDA) is “wrestling with how to exercise its authority over an array of other tobacco products” that have become a popular and cheap alternative to...
A new study in JAMA Dermatology finds that “the burdens of overall medical comorbidity and of specific comorbid diseases increase with increasing disease severity among patients with psoriasis.” Although it is “conventionally considered...
Reuters reports on a U.S. Food and Drug Administration advisory panel recommendation that “Bayer AG’s experimental drug to treat two types of pulmonary hypertension should be approved at doses proposed by the company.” Reviewers for the FDA...